Home › Companies › SHOCKWAVE MEDICAL INC. › 2023-2024

SHOCKWAVE MEDICAL INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and SHOCKWAVE MEDICAL INC.’s Form 8-K, filed 2024-05-30 (Item 5.07 on EDGAR). Page generated 04 October 2026.

7Reported items
462Asset managers
1,992Fund votes
2024-05-29Meeting date

Proxy season: 2023-2024

Explore SHOCKWAVE MEDICAL INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by SHOCKWAVE MEDICAL INC.

These tallies are SHOCKWAVE MEDICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SHOCKWAVE MEDICAL INC. — official shareholder meeting results, meeting held 2024-05-29
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Proposal 1: The Merger Proposal	29,617,472	96,328	9,445	--	0	Majority: yes
Proposal 2: The Compensation Proposal	8,805,656	20,818,045	99,544	--	0	Majority: no

This meeting is also recorded here as 2024-05-28; both records come from the same filing, so the date should be checked against it.

Source: SHOCKWAVE MEDICAL INC., Form 8-K, filed with the SEC on 2024-05-30 — read the filing on EDGAR.

How asset managers voted at the SHOCKWAVE MEDICAL INC. 2023-2024 meeting

Each item below shows how the 462 asset managers that disclosed a SHOCKWAVE MEDICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SHOCKWAVE MEDICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave's named executive officers that is based on or otherwise relates to the Merger.

SECTION 14A SAY-ON-PAY VOTES

Combines 12 wordings of this item as funds reported it.

23% fund support · no official result

FOR 23%AGAINST 76%

The 437 asset managers below cast 23% of the shares they voted on this item FOR (7,291,931 for, 23,937,801 against).

FOR: 7,291,931 (23.3%)AGAINST: 23,937,801 (76.5%)ABSTAIN: 81,881 (0.3%)NOT VOTED: 23 (0.0%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave'” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	0	3,723,201	Against
BlackRock	11,666	3,604,538	Against
Man Group plc	0	1,487,360	Against
Fidelity	558,619	839,135	Against
State Street	1,238,220	19,248	For
Capital Group	40	1,170,000	Against
Pentwater Capital Management LP	0	821,000	Against
HBK INVESTMENTS L P	0	803,614	Against
Invesco	0	689,543	Against
GEODE CAPITAL MANAGEMENT, LLC	620,316	0	For
Wellington	0	582,593	Against
MUTUAL FUND SERIES TRUST	495,400	117	For
Allspring	0	494,696	Against
T. Rowe Price	0	492,863	Against
Charles Schwab	0	464,248	Against
FARALLON CAPITAL MANAGEMENT LLC	455,000	0	For
AllianceBernstein	0	444,005	Against
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	413,464	0	For
UBS	0	406,985	Against
MELLON INVESTMENTS Corp	0	314,723	Against
Northern Trust	0	302,433	Against
Hartford	0	290,104	Against
PRIMECAP MANAGEMENT CO/CA/	276,770	0	For
John Hancock	0	275,769	Against
Janus Henderson	215,684	57,907	For

Showing the 25 largest of 437 asset managers. See all 437 in the interactive database.

2. TO ADJOURN THE SPECIAL MEETING OF STOCKHOLDERS TO A LATER DATE OR DATES AS PROVIDED IN THE MERGER AGREEMENT, IF NECESSARY OR APPROPRIATE, INCLUDING TO SOLICIT ADDITIONAL VOTES IF THERE ARE INSUFFICIENT VOTES TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING OF STOCKHOLDERS.

CORPORATE GOVERNANCE

Combines 4 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 128 asset managers below cast 96% of the shares they voted on this item FOR (12,908,449 for, 494,372 against).

FOR: 12,908,449 (96.2%)AGAINST: 494,372 (3.7%)ABSTAIN: 8,914 (0.1%)

Largest asset managers voting on “TO ADJOURN THE SPECIAL MEETING OF STOCKHOLDERS TO A LATER DATE OR DATES AS PROVIDED IN THE MERGER AGREEMENT, I” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	3,667,225	0	For
BlackRock	2,337,205	0	For
Fidelity	954,909	0	For
Capital Group	585,000	0	For
MUTUAL FUND SERIES TRUST	500,054	0	For
Invesco	319,081	0	For
Hartford	290,104	0	For
State Street	392	254,914	Against
John Hancock	237,867	5,813	For
Jackson National	235,934	0	For
Charles Schwab	231,480	0	For
PRIMECAP Odyssey Funds	215,300	0	For
T. Rowe Price	0	206,809	Against
Allspring	205,874	0	For
JANUS INVESTMENT FUND	200,993	0	For
TimesSquare Capital Management, LLC	181,037	0	For
MERGER FUND	167,516	0	For
JPMorgan	162,021	0	For
AIG/SunAmerica	159,978	0	For
AB DISCOVERY GROWTH FUND, INC.	158,264	0	For
Columbia Threadneedle	144,350	0	For
Investment Managers Series Trust II	132,647	0	For
Equitable	123,217	1,984	For
ARBITRAGE FUNDS	123,042	0	For
Thrivent	108,596	0	For

Showing the 25 largest of 128 asset managers. See all 128 in the interactive database.

3. To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated April 4, 2024, by and among Shockwave Medical, Inc., a Delaware corporation ("Shockwave"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson ("Merger Sub"), pursuant t

EXTRAORDINARY TRANSACTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 81 asset managers below cast 100% of the shares they voted on this item FOR (11,470,441 for, 0 against).

FOR: 11,470,441 (100.0%)

Largest asset managers voting on “To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), da” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Vote
Vanguard	3,667,225	For
BlackRock	2,337,205	For
Fidelity	954,909	For
Capital Group	585,000	For
MUTUAL FUND SERIES TRUST	500,054	For
Invesco	319,081	For
State Street	255,306	For
T. Rowe Price	206,809	For
Allspring	205,874	For
JANUS INVESTMENT FUND	200,993	For
TimesSquare Capital Management, LLC	181,037	For
MERGER FUND	167,516	For
AIG/SunAmerica	159,978	For
AB DISCOVERY GROWTH FUND, INC.	158,264	For
Columbia Threadneedle	144,350	For
Investment Managers Series Trust II	131,447	For
Equitable	119,201	For
Thrivent	108,596	For
First Trust	108,557	For
TIAA	100,510	For
Brighthouse	95,467	For
Managed Portfolio Series	50,767	For
Nationwide	46,084	For
BNY Mellon	38,446	For
Virtus	38,346	For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

4. To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), dated April 4, 2024, by and among Shockwave Medical, Inc., a Delaware corporation ("Shockwave"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson (''Merger Sub''). Pursua

CORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 55 asset managers below cast 100% of the shares they voted on this item FOR (1,942,611 for, 0 against).

FOR: 1,942,611 (100.0%)

Largest asset managers voting on “To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), ” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Vote
Hartford	290,104	For
John Hancock	243,680	For
Jackson National	235,934	For
Charles Schwab	231,480	For
PRIMECAP Odyssey Funds	215,300	For
JPMorgan	162,021	For
ARBITRAGE FUNDS	123,042	For
Prudential/PGIM	63,096	For
NEXPOINT FUNDS I	60,660	For
RBB FUND, INC.	51,501	For
AMG FUNDS	41,700	For
IMPAX FUNDS SERIES TRUST I	30,000	For
Bridge Builder Trust	28,285	For
Mercer Funds	14,804	For
Brown Capital Management Mutual Funds	12,765	For
MML SERIES INVESTMENT FUND	11,616	For
Pacer Funds Trust	10,625	For
Nationwide	9,941	For
SEI	9,425	For
Brighthouse	8,914	For
AltShares Trust	8,874	For
Allianz	8,190	For
Baird	7,954	For
Morningstar Funds Trust	6,552	For
Loomis Sayles	6,276	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

5. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

37% fund support · no official result

FOR 37%AGAINST 63%

The 9 asset managers below cast 37% of the shares they voted on this item FOR (267,326 for, 453,156 against).

FOR: 267,326 (37.1%)AGAINST: 453,156 (62.9%)

Largest asset managers voting on “Advisory Vote on Golden Parachutes” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Against	Vote
JPMorgan	0	314,073	Against
Taconic Capital Advisors LP	188,750	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	0	89,835	Against
Eversept Partners, LP	78,576	0	For
EFG Asset Management (North America) Corp.	0	19,886	Against
Empower	0	16,964	Against
Desjardins Global Asset Management Inc.	0	10,814	Against
Tredje AP-fonden	0	1,584	Against
OARSMAN CAPITAL, INC.	0	0	--

6. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

99.0% fund support · no official result

FOR 99.0%

The 2 asset managers below cast 99.0% of the shares they voted on this item FOR (3,000 for, 29 against).

FOR: 3,000 (99.0%)AGAINST: 29 (1.0%)

Largest asset managers voting on “14A Executive Compensation” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Exome Asset Management LLC	3,000	0	0	0	For
Granite Investment Partners, LLC	0	29	0	0	Against

7. To approve, on a non-binding addvisory basis, the compensation that may be paid or become payable to Shokwave's named executive officers that is based on or otherwise relates to the Merger

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 23,100 against).

AGAINST: 23,100 (100.0%)

Largest asset managers voting on “To approve, on a non-binding addvisory basis, the compensation that may be paid or become payable to Shokwave'” at SHOCKWAVE MEDICAL INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Orion Porfolio Solutions, LLC	0	11,550	0	0	Against
Orion Portfolio Solutions, LLC	0	11,550	0	0	Against

Largest SHOCKWAVE MEDICAL INC. shareholders voting in 2023-2024

Ranked by the number of SHOCKWAVE MEDICAL INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 36,990,700 shares outstanding at the time of that meeting.

Top SHOCKWAVE MEDICAL INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	10.07%
2	BlackRock	9.78%
3	Man Group plc	4.02%
4	Fidelity	3.78%
5	State Street	3.40%
6	Capital Group	3.16%
7	Pentwater Capital Management LP	2.22%
8	HBK INVESTMENTS L P	2.17%
9	Invesco	1.86%
10	GEODE CAPITAL MANAGEMENT, LLC	1.68%

Reported SHOCKWAVE MEDICAL INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

SHOCKWAVE MEDICAL INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock, Inc.	12.36%	DEF14A
The Vanguard Group	9.82%	13G
Entities and persons affiliated with FMR LLC	8.27%	DEF14A
State Street	2.95%	13F
Norges Bank	1.86%	13F
Geode Capital	1.69%	13F
Citadel Advisors	1.66%	13F
T. Rowe Price	1.62%	13F
Douglas Godshall	1.38%	DEF14A
Invesco	1.35%	13F

Percentages above are of 36,990,700 shares outstanding, as reported by SHOCKWAVE MEDICAL INC. on its Form 10-K dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SHOCKWAVE MEDICAL INC.’s 10-K dated 2023-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At SHOCKWAVE MEDICAL INC.'s shareholder meeting held 2024-05-29, in the 2023-2024 proxy season, 462 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,992 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. SHOCKWAVE MEDICAL INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation that may be paid or become… — the reporting funds cast 23% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

SHOCKWAVE MEDICAL INC. proxy season coverage: 2023-2024 (this page).